Not yet recruiting
Study on Immune Response in COVID-19 Recovered Patients Treated with Monoclonal Antibodies: Effects of Revaccination with Elasomeran, Tozinameran, and Cilgavimab
Not yet recruitingRegistered drugNo placebo
Study on Immune Response in COVID-19 Recovered Patients Treated with Monoclonal Antibodies: Effects of Revaccination with Elasomeran, Tozinameran, and Cilgavimab
Registered drugNo placebo
- Substances:Sotrovimab
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Sotrovimab

